Systemic Treatments for Alopecia Areata Registry
NCT06283316
Alopecia, Alopecia Areata
Rotterdam, Netherlands
View Trial DetailsNCT Number: NCT00069589
Alopecia areata is the loss of hair in patches that can proceed to loss of all hair (alopecia totalis or universalis). The purpose of the registry is to collect patient information and blood samples from people with alopecia areata.
This study is active but is not currently recruiting participants.
All sexes
Observational
University of California, San Francisco, San Francisco, California, United States
Alopecia areata is a condition in which hair is lost either from part of the scalp, all of the scalp, or the entire body, and it affects 1% to 2% of the population. It is thought to be an autoimmune disease and in some cases the disease is hereditary. The Alopecia Areata Registry will collect information and blood samples from clinically well-characterized patients with these three forms of alopecia areata: alopecia partialis (patchy loss of the scalp hair), alopecia totalis (total loss of all scalp hair), and alopecia universalis (complete loss of all hair everywhere on the body). This will be a collection of patients in multi-generational families, twins, single patients with patchy, persistent transient alopecia areata or long-standing alopecia totalis/universalis and with controls (persons unaffected and not related to alopecia patients). Information from these patients will be used to search the human genome for disease-associated loci and/or genes. Researchers interested in doing pathophysiology or treatment studies of this disease will also be able to contact patients having the appropriate form of the disease for the studies in question.
Patients who have been diagnosed with alopecia areata by a dermatologist will be eligible for the registry. Patients will fill out an information form online (alopeciaareataregistry.org). Patients who have a family history or specific types of alopecia will be invited to participate in a more detailed questionnaire and physical exam and have blood samples drawn.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Accepts Health Volunteers: Non blood-related individuals who are unaffected with alopecia areata and do not live in the same household with alopecia areata patient.
Time frame: Registration on-going
Database registration of participants via collection of participant epidemiology data.
M.D. Anderson Cancer Center
Other
Alopecia Areata Registry and Immunogenetic Mechanisms
Acronym: NAAR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06283316
Alopecia, Alopecia Areata
Rotterdam, Netherlands
View Trial DetailsNCT05589610
Alopecia, Alopecia Areata
East Melbourne, Australia
View Trial DetailsNCT05098600
Abnormalities, Multiple, Alopecia
Prague, Czechia
View Trial DetailsNCT02812342
Alopecia, Alopecia Areata
New Haven, Connecticut, United States
View Trial Details